Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.
Voskuil FJ, de Jongh SJ, Hooghiemstra WTR, Linssen MD, Steinkamp PJ, de Visscher SAHJ, Schepman KP, Elias SG, Meersma GJ, Jonker PKC, Doff JJ, Jorritsma-Smit A, Nagengast WB, van der Vegt B, Robinson DJ, van Dam GM, Witjes MJH.
Voskuil FJ, et al. Among authors: steinkamp pj.
Theranostics. 2020 Mar 4;10(9):3994-4005. doi: 10.7150/thno.43227. eCollection 2020.
Theranostics. 2020.
PMID: 32226534
Free PMC article.
Clinical Trial.